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Background: Disease management programs, especially those based on the Chronic Care Model (CCM), are
increasingly common in the Netherlands. While disease management programs have been well-researched
quantitatively and economically, less qualitative research has been done. The overall aim of the study is to explore
how disease management programs are implemented within primary care settings in the Netherlands; this paper
focuses on the early development and implementation stages of five disease management programs in the primary
care setting, based on interviews with project leadership teams.
Methods: Eleven semi-structured interviews were conducted at the five selected sites with sixteen professionals
interviewed; all project directors and managers were interviewed. The interviews focused on each project’s chosen
chronic illness (diabetes, eating disorders, COPD, multi-morbidity, CVRM) and project plan, barriers to development
and implementation, the project leaders’ action and reactions, as well as their roles and responsibilities, and disease
management strategies. Analysis was inductive and interpretive, based on the content of the interviews. After
analysis, the results of this research on disease management programs and the Chronic Care Model are viewed
from a traveling technology framework.
Results: This analysis uncovered four themes that can be mapped to disease management and the Chronic Care
Model: (1) changing the health care system, (2) patient-centered care, (3) technological systems and barriers, and (4)
integrating projects into the larger system. Project leaders discussed the paths, both direct and indirect, for
transforming the health care system to one that addresses chronic illness. Patient-centered care was highlighted as
needed and a paradigm shift for many. Challenges with technological systems were pervasive. Project leaders
managed the expenses of a traveling technology, including the social, financial, and administration involved.
Conclusions: At the sites, project leaders served as travel guides, assisting and overseeing the programs as they
traveled from the global plans to local actions. Project leaders, while hypothetically in control of the programs, in
fact shared control of the traveling of the programs with patients, clinicians, and outside consultants. From this
work, we can learn what roadblocks and expenses occur while a technology travels, from a project leader’s point of
view.Background
The diagnosis of chronic disease has increased in the devel-
oped world in recent years, thought to be due to the aging
population and the more successful treatment of acute
illness. Many health care decision makers have been seeking
methods of more efficiently and effectively treating chronic
disease; frequently, these methods include the development* Correspondence: walters@bmg.eur.nl
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reproduction in any medium, provided the orand implementation of disease management programs [1].
While there are many specific definitions of disease man-
agement, for this article and for the projects discussed here,
disease management has been defined as a “broad program-
matic approach to chronic diseases, a comprehensive care
chain that consists of diagnosis, treatment and support, as
well as prevention, early detection, and self-management.
The broad approach is set in multidisciplinary care stan-
dards and is organized around the patient and his illness,
where possible tailored specifically to his environment” [2].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in and tailored by health care providers around the world.
As such, they can be understood as a ‘traveling technology’;
traveling technologies are programs or health care princi-
ples that travel between a global (often academic) stage
and the local practices and actions of health care leaders
and providers. The traveling technologies also include the
“translations that occur when an object travels from one
place to another” [3]. In the process of traveling from the
global (a general program or model) to the local (through
application at a specific practice site), the programs be-
come adapted and negotiated in their local contexts by
project leaders, health care managers, clinicians, and
patients. When viewed as a traveling technology, the local
practices of health care providers and patients are as im-
portant as the global principles that frame those practices.
Disease management programs are an excellent example of
traveling technologies. While disease management pro-
grams originate from similar ideologies of patient-centered
coordinated care, the local actions vary widely, as does the
implementation and in some ways, the redefinition
through the actions of local actors, of the tenets of disease
management.
In this paper, we have collected data from the project
directors and managers of five disease management pro-
grams in the Netherlands. The overall aim of the study is
to explore how disease management programs are imple-
mented within primary care settings in the Netherlands.
For this paper, interviews done with project leadership
teams conducted during the development and early imple-
mentation phases of the disease management programs
have been analyzed from a traveling technologies view-
point. This research provides a unique perspective on trav-
eling technologies by showing how project leaders are
crucial in the traveling of disease management programs at
many levels, as the project leaders interpret, translate,
adapt, and adopt the tenets of disease management pro-
grams to their local settings. This article uses the project
leaders’ point of view to addresses the following question:
 How can disease management programs be
understood as a traveling technology through the
actions and reactions of project leaders?
Disease management programs and the chronic care
model
One of the more popular and pervasive models for framing
disease management programs is the Chronic Care Model
(CCM), which has influenced and been influenced by dis-
ease management programs. The Chronic Care Model
“summarizes the basic elements for improving care in
health systems at the community, organization, practice,
and patient levels” [4]. The model, developed in the United
States by a team led by Edward Wagner in the 1990s, is asynthesis of many components of disease management
programs [5,6]. While there are other guides for disease
management programs, none are as prolific as the Chronic
Care Model; as such, the elements of the CCM will be used
in this paper as a definition of the elements of disease
management.
Much research has been or is currently being conducted
on disease management programs, including those directly
guided by the CCM [7,8], yet little research has focused on
the implementation of disease management programs in
their early phases. As well, there is need for more research
now that disease management programs are increasingly
being taken up in countries outside the US, as can be seen
in Germany [9], New Zealand [10], the UK [11], and the
Netherlands.
Disease management programs are increasingly popular
in the Netherlands, due, in part, to changes within the
health care financing and delivery system. Having under-
gone major reforms in 2006, the new regulated market
health insurance system is continuing to adapt to the needs
of insurers, health care providers, and patients [12].
Through the new system, every resident of the Netherlands
is required to purchase health insurance. The cost of a basic
health insurance plan, which covers preventative and essen-
tial curative services, is fixed; subsidies are available for
those unable to pay. In 2008, the Ministry of Health, Wel-
fare, and Sport emphasized the need to develop disease
management programs for those with chronic diseases [13].
This resulted in the creation, in 2009, of a research and im-
plementation program to improve upon the development
and execution of disease management programs by the
Netherlands Organization for Health Research and Develop-
ment (ZonMw). ZonMw sent out a call for proposals for
projects from practice groups in the Netherlands. The call
for proposals for the projects emphasized the need for dis-
ease management programs that focus on self-management,
co-morbidity, and/or information and communication tech-
nologies (ICT) in health care.
Twenty-two health care provider groups were granted
funding for developing disease management programs. In
exchange for funding, project leaders and clinicians agreed
to develop and implement a disease management program
that meets the needs of their patient population and to fa-
cilitate qualitative, quantitative, and economic research
conducted at the site [14]; five were selected for further in-
depth qualitative research, based on maximum variation
between diseases and practices. Through the qualitative re-
search, the research team will explore how disease manage-
ment programs are implemented in the Netherlands by the
project leaders and clinicians. This research also included
how disease management programs move from plans to
actions, how the programs are altered and tailored to the
situation, and, toward the end of the project timeline, how
clinicians and project leaders embed notions of disease
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project sites, under the guidance of their project leaders,
selected the chronic condition that they would like to ad-
dress to improve the health care of their patients. The pro-
ject leaders developed project plans, often with intensive
feedback from health care providers, and submitted the
plans for funding to ZonMw. ZonMw funded the projects
thought to be most likely to succeed and impact a large
population of patients with chronic disease.
Methods
The qualitative study is part of a larger effort to understand
the impact of disease management programs on clinical
systems, clinician behavior, patient perception of care,
health outcomes, and on the financing of treatment. The
larger goal of the qualitative component of the study is to
understand the impact of developing and implementing
disease management program on project leaders, clinicians,
and patients; this paper looks at the impact on project lea-
ders, while future work will look at the clinicians and
patients. The study was approved by the Review Board of
Erasmus MC.
Settings/study sites
The five qualitative sites were selected as a purposeful sam-
ple on the basis of maximum variation, with respect to the
planned development and use of information and commu-
nication technologies, interaction between primary and
secondary care, type of intervention, role of the patient,
and changes for professionals. They also represent a range
of chronic conditions, including eating disorders, diabetes,
and cardiovascular risk management.
Research participants
Each study site has a project leader or a project leadership
team, including project leaders who manage small projects
within the large disease management project (known in
this article as mini-project leaders), to guide the work of
the program and project; many of these main project lea-
ders or managers have had training prior to the study (as
part of a Masters or as separate certification courses in
health care organizations) in health care systems or disease
management, though this was not a requirement of the
programs or study. While many of the project leaders have
education in health care management and program leader-
ship, it is unclear to what degree project leaders were
cognizant of the specific literature on the Chronic Care
Model. The project leaders oversee the projects, work with
clinicians at each GP office or department, collaborate with
the research team on the economic, qualitative, and quan-
titative research, and develop and/or tailor the disease
management program. Furthermore, the project leaders
support projects by being contact points for ZonMw and
for the two other supporting agencies, Vilans and Picassofor COPD. The project leaders are also expected to attend
Inspiration Days, one-day conferences that address themes
of interest to the projects, such as eHealth programs, pro-
gram leadership, and patient education. The project leaders
are granted much latitude in how the projects are con-
ducted, though support and education is available on
request.
Design
At each of the five selected sites, semi-structured inter-
views were conducted with the project leaders and mem-
bers of the project leadership team. Eleven interviews were
conducted at the five selected sites with sixteen health care
professionals; all of the interviews were conducted by the
first author. The interviews were conducted at the program
site in Dutch or English and ranged from 45 minutes to 90
minutes. The interviews were recorded; equipment mal-
function resulted in two interviews with missing record-
ings. In all cases, in the event of equipment malfunction,
the interviewer took detailed notes, including exact quotes
from the interviewees, during the interviews. Interviews
were transcribed verbatim. The interview quotes used in
this manuscript were sent to the respondents in order to
confirm use in the manuscript, as well as check any confu-
sion in language. The respondents edited the quotes with
minor changes and gave express permission to use the
quotes in this manuscript.
Table 1 gives an overview of the sites; Table 2 sum-
marizes the interviews conducted at each site. All project
leaders were interviewed about their projects, their practice
settings, and the changes being made as a result of the de-
velopment and implementation of the disease management
project. Table 3 outlines the major themes uncovered in
the data collected from the interviews, including the
themes covered in this manuscript, as well as other themes
that will be explored further in future articles.
Baseline interview questions were developed from the lit-
erature in disease management [15,16], the Chronic Care
Model [17-19], and conditions related to each site [20-24].
Further questions were developed after a review of the data
collection methods of the quantitative and economic
aspects of the study; the first author also met regularly with
the economic and quantitative researchers and discussed
the qualitative data collection to ensure harmony and in-
clusiveness of the qualitative data collection within the
overall study goals. The qualitative data collection ques-
tions also cover areas that are not fully addressed by eco-
nomic and quantitative aspects of the study to ensure
complete data capture for the entire study, such as barriers
to implementation at this point, challenges to the develop-
ment of the project, an exploration of the team dynamics,
communication strategies used with the project team, and
any (un)pleasant surprises that they have encountered.
Project leaders were asked about their own experiences in
Table 1 Projects selected and interviewed for qualitative research




Eating disorders On-site leadership team 1 project leader (MD) 1
project manager (Social worker) 4 mini-project
leaders
4 fold project to reduce barriers to access to
support and treatment for eating disorders
GP practice group Cardiovascular risk
(CVR) management
On-site leadership team 2 project leaders (MDs) 1
project manager (RN)
Manage CVR through patient portals, patient care
plans, and interdisciplinary care teams
GP practice group Diabetes Consultant leader 1 project leader (Health care
consultant)
Train clinicians and other health care givers to
manage diabetes in first line care
GP practice group Chronic obstructive
pulmonary disease
(COPD)
Consultant leader 1 project leader (Health care
consultant)
Find and recommend an effective ICT system and
an expert COPD training team visiting each practice
GP practice group Multi-morbidity Consultant leaders 2 project leaders (MD, RN) Develop integrated approaches for the
management of co-morbidity and chronic illness
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agement programs, as well as any interest or criticisms that
they had heard from other professionals and clinicians
involved in the disease management programs. While the
answers to these questions were analyzed from a traveling
technology framework, the questions themselves map back
to the primary aim of the study, understanding how disease
management programs are implemented in primary care
in the Netherlands; Table 4 has a sample of the interview
guide. From this information, the research team was able
to gather information about how the disease managementTable 2 Interviews conducted
Project site Interviews
Clinic for eating disorders
and addictions
One-on-one interview with project leader
One-on-one interview with project manager
Three one-on-one interviews with
mini-project leaders




GP practice group Joint interview with project leaders
One-on-one interview with project manager
Total interviews:
2
GP practice group One-on-one interview with project leader
Total interviews:
1




GP practice group Joint interview with project leaders
Total interviews:
1programs were being implemented in the sites, as
well as how the disease management programs were
best understood as traveling technologies as they were
implemented and altered by the project leaders.
Analytical approach
Analysis was inductive and interpretive, based on the
content of the interviews; in line with the inductive
analytic tradition, project leaders were frequently
asked to define terms that are otherwise taken for
granted as a shared understanding, such as ‘disease
management’ [see Table 4]. The content of the inter-
views focused on the implementation of the disease
management programs by the project leadership team,
communication and team dynamics between members
of the project leadership team, the clinicians, and the
patients, and changes in health care practices, based
on the diseases addressed in the programs. This
method of inductive analysis allows for the develop-
ment of general themes mapped back to the literature
[25]. As disease management programs contain many
of the aspects of a traveling technology (traveling
expenditures, movement from global to local arenas),
the data collected through interviews with the project
leaders was most clearly understood through a travel-
ing technologies framework. All research questions
have been analyzed using the same method. The data
was coded by the first author and verified through
close reading of the quotes in their original language
and their translation, when appropriate, by the second
author, SA.
Results
From the empirical data, four disease management
themes, as defined by the Chronic Care Model, emerged:
(1) changing the health care system,
(2) patient-centered care,
(3) technological systems and barriers, and















Reducing the use of specialists
Barriers
Communication
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system.
Illustrative quotes from these themes have been selected
from this article and are seen below in italics and off-set
from the text. Through defining disease management
through these Chronic Care Model themes, the research
team was able to understand and explore how disease man-
agement programs travel. This research shows how project
leaders manage and interact with the members of the dis-
ease management programs, and ultimately, the patients
and clients impacted by the disease management programs,
as well as how project leaders view the travel expenditures
associated with the programs.Changing the health care system
Project leaders and project leadership teams, including
project managers and mini-project leaders, frequently tiedTable 4 Sample from the interview guide
1 Why were the projects developed?
2 What is the need?
3 What are the barriers to implementation?
4 How does communication happen?
aAs a team
5 What has feedback been to the implementation from staff?
6 How has your team helped in the creation and implementation of the
project?
7 How was your team developed?
8 What does it mean to have a disease management system or project?
9 What good surprises have you had?their disease management project work to larger efforts in
health care and in their health care system’s delivery of care
in specific. Project leaders sited the goals of the programs
as the impetus to plan (and in the future, put in place)
changes, as well as the goal of improving patient care.
The end goal is to reach more people in a better way
with a continuous quality of care during the, on
average, 5 to 7 year illness period. That’s the idea.
That’s ambitious. Yeah, it’s very exciting because we
have to change the whole way of thinking here and
change the whole organizational model as well. . . So
we have inner barriers to continuity in care as well.
Lack of flexibility there as well, so we need to
reorganize internally this year. (Interview with E,
project director for the eating disorder project)
The latitude afforded to the project leaders in developing
their programs means that the translation from the project
plan on paper to action in practice can be done in a num-
ber of ways: as a drastic reorganization, in phases, or first
as a project with later spoken or unspoken plans for inte-
gration into the system. It also involves translation work in
relationship to stakeholders:
I have to tell [the GPs] that it’s just a project and that
we will need an evaluation of the project before it
comes to be common practice. (Interview with X,
project leader with the CVR project)
Patient-centered care
Patient-centered care, as defined by the Chronic Care Model
through the Self-Management Support element of the
model, highlights “the patient’s central role in managing their
health” [26]. While the majority of the project leaders did
not mention the Chronic Care Model as inspiration for the
changes that they plan to make, a few did and directly tied
their actions to the model.
For example, that together with the patient, you look
at the self-management of that patient and that you
look according to the Chronic Care Model, like yeah, I
have to work along with the patient on all the factors
and not only give information, because that isn’t going
to help that patient. That’s what is important, that I
can see now in a broad perspective and then you can
make the most of giving care. (Interview 1 with H,
project manager with the CVR project)
And then another thing was the Chronic Care Model
is a patient-centered model. And we are not used to
working [in a] patient-centered [way]. It’s becoming
more and more [popular]. What’s new in our system is
that we choose to work in a patient-centered way.
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However, as noted in the quote above, working in a
patient-centered way is a change within the system, a
change that costs time and effort. This expenditure of time
and effort is for a common goal: involving patients in their
health care to improve their health.
Well and involving the patient now is one of the most
important things because what we’ve discovered and
what worldwide they discovered is that lifestyle change
is one of the most important issues that can make a
difference on the long term, but is also one of the most
difficult things to realize. And the only way to do that
is getting patients involved, and getting them to
participate in their own disease. (Interview with B,
project leader for the diabetes project)
Project leaders emphasize how becoming more patient-
centered impacts the providers and how providers will
need to change how care is delivered.
The two things that are the most important are the
self management of the patients themselves because
the patient is the main issue of gaining a long term
benefit out of the system. So that’s one thing. But
what’s also necessary is that the care givers, the
doctors, the physicians, the nurses, they have to make
a switch in not only being a health care giver but
being a coach, being able to give the support to the
patient that they can make their own self-management
system and that they can make their own choices and
that will really make a difference, instead of the choice
of the health care giver. (Interview with B, project
leader for the diabetes project)
Other project leaders place emphasis on the changed role
of the patient and their involvement in their care process.
But it’s the process of the client, not the process of the
one who’s giving the support. So the process of the
client is leading. That’s a difficult part of it, but the
essential part of it. Do you know what I mean? I
mean. . . I can tell you what you’ve got to do to
recovery, what’s good for you. But that won’t be
necessarily your way. . . .I’ve got to connect with your
approaches. And look together with you and support
you to empower you to find your own path in recovery.
(Interview with P, mini-project leader for the eating
disorder project)
Patient-centered care can be a challenge for health care
providers, as it may require them to change the ways in
which care is presented and delivered to patients. Health
care providers must think and act in new ways, as well ascontinue to alter their health care systems to sustain this
new way of providing care.
The challenge is to know who needs support and who
can self- manage. (Interview with H, project manager
for the CVR project)
To learn to think about the client is the most difficult
thing [to do]. To really think about the client. Not that
I know what is best for the client. The client knows
best. That’s a hell of a job. (Interview with K, project
manager for the eating disorder project)
Technological systems and barriers
For the project leaders, implementing a disease man-
agement program is a process of harmonizing the
movement of information and actions between prac-
tice sites, patients, and the project leaders. In all
cases, this change to the health care system involves
new communication technology. The improvement
or addition of a technological system is a common
way to change the mode of health care delivery and
is emphasized in the call for proposals for the pro-
jects. The planned changes in the projects include
the development of patient portals to assist patients
in self-management, patient health records, compu-
terized communication systems to connect general
practitioners and other health care professionals, and
websites for patients/clients to connect with clini-
cians and others. These changes are seen as import-
ant for organizing and improving care for both
patients and clinicians.
So now all general practices have their own
registration and programs. And we think it’s very
important that the general practices and the hospital
work together and can see the registration and can
communicate together. And we think that we need
another program for that. (Interview 1 with AC,
project leader for the COPD project)
But what is especially important and that’s where we are
now spending a lot of time is to properly organize care with
the GPs who work on a computer. (Interview with H, pro-
ject manager for the CVR project)
However, ICT systems are also seen as a barrier, in that
the development and implementation of the systems is
costly in both time and effort. Project leaders must also
spend time prioritizing and in some ways, limiting, the
focus of the ICT system.
We have a lot of barriers. First barrier is with the ICT
system. It’s not already finished. . . It was a long step to
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leader with the CVR project)
The fact that the software builder couldn’t deliver
what they said they would deliver [was a barrier]. And
still now we do not really have the perfect system and
the perfect system does not exist, I know. But there are
too many things that are really what we want.
(Interview with B, project leader for the diabetes
project)
And you have the program, and it’s sort of the same,
and it works on the mobile phone. And E. thought that
it would be a program that worked on the Internet
and on the mobile phone. And there are two programs,
but the content is different, so you have only
prevention on the Internet or after care on the SMS. So
there were all kind of technology things that had to be
discussed before we decided what to do. (Interview
with M, mini-project leader for the eating disorder
project)
Patients and clients, too, play a role in the develop-
ment of an ICT system. Depending on the system,
patients and clients will be able to interact directly with
clinicians through a website or patient portal, clinicians
at multiple locations will have the ability to interface
with a patient’s record, and/or project leaders and clini-
cians will be able to review the information of large sets
of patients for patterns and quality control.
They [the patients] can choose their treatments. And
all those steps we have laid out in our ICT scheme.
(Interview with X, project leader with the CVR
project)
However, not all patients are expected to want to directly
participate in an ICT system or have the skills to do so at
this time.
Well there are patients who say “I do not want that
my information is put in the software system” so we
have a form that they can sign if they do not what
that. (Interview with B, project leader with the
diabetes project)
Integrating projects into the larger health care system
As the projects are funded for a short amount of time, the
project leaders recognize the need to integrate the projects
into the larger health care system if they want to make last-
ing changes to the delivery of health care. This effort to
integrate projects into routine care often involves the devel-
opment of program plans, budgets, the hiring of new staff,
and/or the training of existing staff. Some project leaders seethe projects as an opportunity to expand the scope of the
projects and create a system for the management of chronic
disease in general at their sites.
The third step is to make the disease management
program a multi-morbidity program. These steps are
further integration into chronic care. The project is a
model for all future chronic care programs. We don’t
believe in a system for separate projects formulti-
morbidity. . . One program. (Interview with V, project
leader for the multi-morbidity project)
And the second thing there is trying to make it more a
disease management than only one chronic care
model. For COPD and cardiovascular, we know that
we are going to introduce also the chain system, so
we’re trying to make the base ready for other chronic
care systems. (Interview with B, project leader for the
diabetes project)
Other members of the project leadership team are
working with clinicians to imbed the current changes
into the current health care delivery system. So they
have to integrate it in their daily work. . .in their
practice. That’s a very big step to get it implemented
there and instruct all the other employees in the
practices. (Interview with R, outside expert at the
COPD project)
However, project leaders find that working with clini-
cians to think beyond the project and beyond their cur-
rently defined roles can be a challenge.
That’s the biggest challenge. Because we are all
professionals at this moment. It’s very difficult to
connect the clinic with the outpatient clinic. Ah, I
think that we are, as professionals, able to want to
look further than our little business. It’s the same old
story with all the professionals in health care.
(Interview with K, project manager for the eating
disorder project)
For the project leaders, the disease management programs
are an iterative process, with ongoing efforts made to im-
prove the programs and the care that they help provide.
The program is not the answer, only an answer. We
have to have the courage to change again without
always being on the move. (Interview with S,
department head at the eating disorders project)
Discussion
In this study, disease management programs, as defined by
the elements of the Chronic Care Model, are analyzed as a
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translations, adaptations, and expenditures that occur when
an object or program moves from one location to another;
traveling is more than the translation of the disease man-
agement projects, as it encompasses the translation of the
disease management programs to the local setting, but fo-
cuses on the travel expenditures and travel documents cre-
ated in the process [27]. As a result, project leaders play an
important role in this process, especially during the devel-
opment and early implementation phases. It’s important to
note that the traveling expenditures of the programs are
much more than financial and include the social costs and
changed expectations, the administrative effort, and the
altered obligations for patients and staff; these traveling
expenditures are often hidden and in many ways, unex-
pected by the project leaders.
Through management and organizational work, the pro-
ject directors serve as ‘travel guides’ for the programs, as
they oversee the expenditures of the programs, help guide
the travel of the disease management programs to an indi-
vidual clinician’s offices, assist clinicians involved in the pro-
jects in the travel of the programs to and with patients, and
connect the disease management programs to a global dis-
ease management community. Much of this work involves
the creation and management of documents involved in
each of the aspects of the disease management programs;
these documents include framing documents, such as
revised project plans, and communication documents, such
as emails to clinicians and newsletters. Each aspect or
theme of disease management (changing the health care
system, patient-centered care, technological systems and
barriers, and integrating projects into the larger health care
system) involves the creation or management of documents
or communications (including telephone and in-person
communication) by the project leaders. As can be seen in
the interviews, project leaders were frequently communicat-
ing with the clinicians and editing ICT plans to match
the available computer programs. These documents travel
the technology, both literally (as a newsletter moves from
the project director to the clinician) and figuratively (as the
documents house strategies and networks for the traveling
of the programs).
While disease management programs have been widely
touted as a method of reducing costs in health care deliv-
ery, research shows that the implementation costs can have
a large financial impact [28]. However, the costs of devel-
oping and implementing a disease management program
are more than money and effort. These traveling expendi-
tures include the making and managing of program docu-
ments, the developing and maintaining of relationships
and networks, the re-shaping of roles and responsibilities
of patients and clinicians, and the adapting and moving of
regulations and policies [29]. In the five disease manage-
ment programs, we see that project directors are aware ofthese traveling expenditures. This can be seen in the pro-
ject leader’s statements about the development and imple-
mentation of ICT systems, as well as in discussions of
clinician training. The time needed to refine and develop
the programs, to manage the timeline of the programs in
relation to the ICT system, and to negotiate relationships
with software developers are all expenditures that the pro-
ject director must manage, even when many of the expen-
ditures are out of his/her control.
While it might be assumed that as ‘travel guides’, the pro-
ject directors are in control of the projects, this is not un-
varyingly true. In fact, control and traveling of the programs
shifts between the project director, outside contractors, clini-
cians, and patients. In some cases, the project director ac-
tively moves the control, such as by working to change the
role of the patient to one that is more self-managed, while
in other cases, both the control of the programs and its trav-
eling moves in spite of the actions and desires of the project
director. This movement of control can be seen in the pro-
ject directors’ statements about the development of ICT
programs and in their thoughts on the challenges associated
with the changed roles for clinicians in regard to patient
self-management. However, while the project director may
be (in title and in role) in charge of the project, the traveling
of the disease management programs is also reliant on the
actions (and inactions) of the local clinicians, patients, and
outside contractors.
The disease management programs, in line with the ele-
ments of the Chronic Care Model, are implementing some
form of computer-based health system. These computer-
based health systems are designed to enable the flow of in-
formation between clinicians in multiple locations, connect
clinicians and patients, and organize the work of the pro-
grams through communication and the posting of project
plans and meeting notes. Yet computer-based health sys-
tems in general are still a work in progress for the techno-
logical developers and for the end-users [30]. Implementing
computer-based systems is a major undertaking for health
care organizations, needing support, organizational, cultural,
and technical changes [31]; even when implemented, the
computer-based system may not provide the improvement
in care desired, but may increase mistakes in medical record
documentation, medication dosing, and may, in fact, be
more difficult for clinicians to use [32]. Developing and
using computer-based systems to travel the program to and
between health care providers, project leaders, and patients
is not a simple task but is a ‘mutual shaping’ of expectations
and goals [33]. This mutual shaping can be seen in revised
project plans for ICT systems, as well as extended timelines.
Better care for patients with a chronic condition is one of
the main goals of the disease management programs. Project
directors see disease management as a patient-led journey
(it’s the process of the client) that focuses on the needs of the
patient (the client knows best) through self-management.
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to the program (to move clients to the clinic) and the
program to the patients. In line with the traveling technol-
ogy framework, project directors use movement verbs when
discussing patient involvement in the disease management
program, highlighting the actions that the project directors
are taking to move the program to the patient. Yet, in line
with literature on self-management [34], project directors
see that self-management has challenges and limitations (the
challenge is to know who needs support and who can self-
manage). Through their understanding of these challenges
and limitations, project directors work to find ways to travel
the programs to the patient in a way that is appropriate and
thought to be acceptable to the patients (one is to provide
adequate information but not in professional language but
in language that appeals to teenagers, so anecdotally, but to
provide information which is at least scientifically accurate).
While traveling the programs to patients and to the clini-
cians involved in the programs, project directors also see
their work as connected to a larger global arena. Globalized
language is apparent in the projects (all the professionals in
health care, what worldwide they discovered), tying the
project leaders and the projects to a larger movement in
health care. The project travels from the global, as defined
by the elements of the Chronic Care Model, to the local
health care providers. Project leaders are aware of the in-
fluence of outside models, with some referencing the
chronic care or the Chronic Care Model as an influencing
factor, and are cognizant of the longer term implications of
the projects (The project is a model for all future chronic
care programs.). This awareness leads to broader efforts
when developing the programs, as well as a willingness to
be influenced by larger trends within health care (look
according to the Chronic Care Model). The project leaders
are responsible for traveling to and from the large global
sphere.
Research on disease management programs and the
Chronic Care Model is increasingly relevant, as health care
systems are turning to disease management programs to
treat the rising number of patients with chronic diseases.
While other research has focused on the implementation of
the Chronic Care Model in Belgium [35], where the care of
patients with chronic disease is delivered in primary care
setting within a limited structure, this research focuses on the
primary care setting in the Netherlands; in the Netherlands,
the primary care setting is the typical setting of disease man-
agement programs for the care of patients with chronic
diseases, including those studied in this article. Similar to
the findings in this article (I have to tell [the GPs] that it’s
just a project), research conducted in one large health care
organization implementing programs based on the Chronic
Care Model found that physician engagement could be diffi-
cult due to lack of commitment, lack of time, and change
fatigue [36]. Other researchers in the US have shown thatwhile health care organizations using collaborative teams
can make substantial changes in the delivery of care for
patients with chronic diseases, these changes can be difficult
to maintain at the same level of intensity [37]. As the
research conducted in this article is during the planning and
early implementation stages of disease management pro-
grams, it will be useful to observe the evolution of the dis-
ease management programs as a traveling technology over
time.
This article presents information that could benefit pro-
ject leaders of disease management in understanding the
longer term implications of their work in both global and
local arenas. This information could be especially useful to
project leaders within the Netherlands or who are new to
disease management programs. This data shows how pro-
ject leaders adapt to and adopt new systems. The qualitative
data on which this article builds give important insights
into how project leaders, especially project leaders who are
new to disease management programs, struggle with and
overcome challenges involved in interacting with a traveling
technology such as the Chronic Care Model. Understand-
ing how project leaders struggle with and overcome these
challenges will help facilitate the development of better
supportive structures for disease management projects, as
well as the development of more comprehensive project
plans and budgets.
However, the paper is limited by the number of inter-
views. As the interviews were conducted in the early stages
of the programs, only 11 interviews are available. In the
case of the eating disorders project, where multiple mini-
projects are being conducted as part of the larger disease
management project, each mini-project leader was inter-
viewed. As this research follows the project leaders and
programs over time, this will be improved in future papers
and will show not only how project leaders work with and
through the Chronic Care Model, but will also reveal how
GPs and other clinicians adapt and adopt to the project lea-
der’s guidance. While the limited number of interviews
may impact the conclusions, the use of these interviews is
still relevant; the mini-project leaders serve a similar role as
the project leaders at other sites, overseeing the projects,
the project staff, the timeline, communication with patients
and/or other clinicians, and the content of the mini-project.
Conclusion
This study has revealed that disease management project lea-
ders serve as ‘travel guides’ when a disease management pro-
gram is a traveling technology and adds to the understanding
of how disease management programs are developed and
implemented in the primary care setting. Through the project
leaders’ interpretation, translation, adaption, and adoption of
the tenets of disease management, as well as through the
management of travel expenditures, the disease management
programs travel not only from global notions of disease
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within the network of the project teams: from the project
plan to implementation, from the project leader to the clini-
cians, from the clinicians to the patients.
As ‘travel guides’, project leaders should be aware that
the impact of their work is both deeper and broader than
they may realize, as the disease management programs are
traveling throughout their project teams. In many ways,
project leaders set the overall tone of the project – the
focus and the sentiments behind the disease management
program. Their work not only guides the overall project,
but impacts the interaction of one clinician with one pa-
tient, as well as traveling to the broader disease manage-
ment arena through participation in research, through the
development of care consortiums, and through the honing
of standards and protocols within the Dutch health care
system.
Understanding the beginning stages of implementing a
disease management program (at the project leader level,
as well as at the health systems level) can be helpful for
other programs and health systems. Other health care clin-
icians can benefit from this work by understanding that
the development and implementation of disease manage-
ment programs is also the implementation and develop-
ment of a traveling technology, with associated traveling
expenditures and roadblocks. Through this, other project
leaders can understand their work has broader implications
both within their own program and as part of a larger dis-
ease management community. Much can be done at the
project development phase to aim for smoother implemen-
tation, though every project will still face travel expendi-
tures. Project leaders should pay more attention to the
lasting effects of their work in all of the arenas it touches.
This attention can come through more forethought on the
implications of their project as a traveling technology,
more research on the various elements involved in the pro-
ject, such as ICT systems, and more funding allocated to pro-
ject leadership and project leadership development during the
development and early implementation phases of the project.
Project plans can allow for more hours for project leadership,
as well as a more flexible timeline to allow for overcoming
roadblocks and overseeing traveling expenditures.
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